LLY vs AZN: Fair Value Comparison

Eli Lilly and Company vs. AstraZeneca PLC · General Drug Manufacturers

LLY's model fair value sits 46.2% below its current price; AZN's model fair value sits 7.2% above its current price. Of the two, AZN trades further below its model estimate. Model estimates under stated assumptions. Data as of 2026-10-22.

LLYAZN
Price$1308.30$172.50
Model fair value (multi-method blend)$704.33$184.89
Model fair value differential-46.2%+7.2%
Methods with a model value above price10 of 107 of 10
Fundamental strengthA-A-
Next earnings report2026-10-292026-10-30

Differential = model fair value versus the current price; positive means the price sits below the model estimate.

More comparisons

LLY vs JNJ · LLY vs ABBV · LLY vs MRK · LLY vs NVS · JNJ vs AZN · ABBV vs AZN · MRK vs AZN · NVS vs AZN · All General Drug Manufacturers stocks · Compare any two stocks